CONNECT WITH US
Web3 & Blockchain

Web3 & Blockchain

INJ Price Prediction: Momentum Flatlines Below Short-Term MAs as Sell Volume Takes Control

Blockchain.News logo

Published on

Add as a preferred source on Google
INJ Price Prediction: Momentum Flatlines Below Short-Term MAs as Sell Volume Takes Control

Injective fell 2.35% over the past 24 hours to $7.55 on Binance spot, trading below all four short-term moving averages while the MACD histogram converges to zero and taker sell volume outpaces buy...

Market analysis includes conditional scenarios, not assured price outcomes or investment advice. Check the data, assumptions and dates cited.

At $7.55 as of the October 25 generation date, INJ sits below every meaningful short-term average. The SMA 7 stands at $8.16, the SMA 20 at $7.97, the EMA 12 at $8.04, and the EMA 26 at $7.85 — all forming a compressed resistance cluster between roughly $7.85 and $8.16. The 24-hour range of $7.43 to $7.78 confirmed that buyers have not been able to sustain any push back toward that cluster on Binance spot.

The longer-term picture is structurally different. The SMA 50 sits at $7.36, just below the immediate support level of $7.39, providing a medium-term reference point the current price has not yet violated. More starkly, the SMA 200 remains at $5.37 — roughly 29% below spot — meaning that despite today's weakness, INJ trades well above its long-term average baseline. That long-term context does not rescue short-term momentum, but it does define the broader range of perspective.

0000. When the histogram crosses to zero, it marks the point where prior bullish momentum has fully dissipated. The question the data cannot answer is whether this becomes a launching pad for the next leg or a pivot into negative territory. The histogram alone does not supply the answer — subsequent candles will determine that.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.